Answers are grounded in this paper and cite their sources.
Objective To evaluate the clinical outcomes of diamond burr debridement (DBD) combined with bandage contact lens (BCL) placement for treatment of feline corneal sequestra (FCS). Methods Medical records of client-owned cats diagnosed with superficial FCS and treated with DBD and BCL between October 1, 2022, and April 1, 2026, were retrospectively reviewed. Diamond burr debridement was performed under topical anesthesia using a handheld diamond burr, followed by BCL placement. Clinical assessments included lesion width, epithelial healing rate, recurrence, and postprocedural corneal opacity. Correlations between lesion characteristics and outcomes were analyzed using the Spearman ρ test. Results 17 cats (17 eyes) met the inclusion criteria. Mean age was 8.0 ± 3.0 years (range, 3 to 14 years), and 13 of 17 (76.4%) were brachycephalic breeds. Complete corneal epithelialization occurred in 14 of 17 eyes at 2 weeks and in 3 of 17 eyes at 4 weeks after procedure. Blepharospasm, epiphora, and conjunctival hyperemia resolved in all cats. Recurrence occurred in 4 eyes (23.5%). Spearman correlation analysis revealed a positive correlation between lesion size and recurrence (ρ = 0.684). Lesion size was negatively correlated with the presence of a BCL at recheck (ρ = –0.502), and recurrence was negatively correlated with the presence of a BCL at recheck (ρ = –0.523). Conclusions DBD with BCL placement may be considered as a minimally invasive treatment option in carefully selected cats with superficial FCS. Clinical Relevance Superficial keratectomy remains the gold-standard treatment for FCS. Careful assessment of lesion depth and strict case selection are essential when considering DBD, particularly because deeper stromal involvement may require complete sequestrum removal and structural repair.
No takes yet. Share an insight, caveat, or question.
Sung et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: